Sixth Street, KKR Provide BridgeBio $1 Billion Preferred Equity

Sixth Street Partners and KKR & Co. agreed to provide $1 billion in preferred equity to BridgeBio Pharma Inc. The investment was announced by the parties involved. BridgeBio is a biotechnology company.

Next story